VLAIO funding
Innovation happens when diverse fields join forces
MEDVIA provides earmarked, non-dilutive funding – made available by Flanders Innovation & Entrepreneurship (VLAIO) – to consortia developing disruptive solutions for unmet medical needs.
Consortia applying for funding must consist of companies or organizations from at least two of the three healthtech fields supported by MEDVIA: medical technology, biotechnology and digital health.
We publish two calls for funding per year, in January and in June. We announce these calls on our website, in our newsletter and via our social media channels.
Different needs, different funding instruments
VLAIO provides multiple kinds of grant options, depending on the needs of the project.
Current open calls for VLAIO funding:
2024.1
2024.2
Flanders, Belgium and Europe offer a wealth of options for project funding for healthtech companies and research institutions, from concept to breakthrough and from start-up to scale-up and beyond.
Not sure which funding option is right for you?
By signing up you agree with our Privacy Policy
Better together
and
are joining forces in a brand new organization
The members of MEDVIA and flanders.bio have voted to merge their activities in the first half of 2025. With a united voice, we will champion the entire healthtech and biotech ecosystem on the regional, federal and European stage.
The merger allows MEDVIA and flanders.bio to align activities and deliver more powerful support for our collective members. We will achieve greater impact with more dynamic networking opportunities, better directed funding and increased efficiency, sharpening our focus in common areas and drafting strategic roadmaps for Flanders.